New search | Conferencedetail
mail
Print view
 
 

2nd Fc Receptor & IgG Targeted Therapies Summit

Evvnt Promotion / evvnt
-
26.04.2022 - 28.04.2022  Hilton Boston Back Bay, 40 Dalton Street, 02115 Boston, USA
Time: 9:00 AM - 4:00 PM
 
Conference themes
FcRn, Fcγ, and IgG studies have been propelled by drug developers recently after Argenx’s potential FDA’s approval of first-in-class FcRn antagonist efgartigimod, AstraZeneca-Alexion’s $39 billion deal, and positive clinical updates from UCB’s Rozanolixizumab. Successful modulation of the Fc pathways and optimized IgG antibodies have proven clinical utility and demonstrate significant therapeutic potential with more players poised to bring their candidates through clinic.
Professional congress organizer (PCO)
Hanson Wade
 

Enquiries and Registration:

https://go.evvnt.com/972245-1?pid=4832
Ms. Erin Thomas
 
Categories
General Medicine
Languages
English
Congress fees
Conference + 2 Workshops - Pharma Biotech USD 3897.00, Conference Only - Pharma Biotech USD 2999.00, Conference + 2 Workshops - Service provider USD 4697.00, Conference Only - Service provider USD 3599.00
Participants expected
1000
Organizer contact info
83 Great Titchfield Street
W1W 6RH London
United Kingdom
 
"Going International promotes access to education and training for all regardless of social, geographic and national borders."

Anästhesie in Entwicklungsländern e. V.Ärztekammer für WienHilfswerk AustriaHelix - Forschung & Beratung WienCharité International AcademyOÖ Gebietskrankenkasse, Referat für Wissenschaftskooperation Österreichische Gesellschaft für Public HealthCentro per la Formazione Permanente e l'Aggiornamento del Personale del Servizio Sanitario